Here are the 424B prospectus supplements from Wrap Technologies, Inc. (WRAP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow WRAP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WRAP filings page.
Wrap Technologies, Inc. is conducting a shelf takedown offering of 5,771,519 shares of common stock at $1.40 per share and pre-funded warrants to purchase up to 2,800,090 shares at $1.3999 per warrant, with an exercise price of $0.0001 per share. Gross proceeds are expected to be $11,999,972.59, with net proceeds of approximately $10.8 million after a 7% placement fee and estimated expenses. The company plans to use the funds for working capital and general corporate purposes, including future business expansion. Common shares outstanding are expected to be 64,576,572 after the offering, assuming full exercise of the pre-funded warrants, versus 56,004,963 shares outstanding as of August 14, 2026. Pro forma net tangible book value would rise from $0.21 to $0.36 per share, implying an immediate dilution of $1.04 per share to new investors buying in this offering.
Wrap Technologies, Inc. is registering up to 5,000,000 shares of common stock for resale by existing investors, made up of 1,700,000 already-issued shares, 2,500,000 shares underlying common warrants, and 800,000 shares underlying pre-funded warrants, all from a February 2026 private placement.
The company previously raised approximately $5.0 million in gross proceeds in that private deal. It will not receive any cash from resale of these shares, but could receive additional funds if investors exercise common warrants at $2.30 per share. The warrants are immediately exercisable and common warrants expire five years after issuance. A 4.99% (or, at holder election, 9.99%) beneficial ownership cap limits how many shares each holder can own after exercise.
As of February 6, 2026, Wrap had 54,501,638 common shares outstanding, and issuing all shares covered by this prospectus would add about 9.17% to that count. The filing warns that resale of a large block of shares, together with anti-dilution features in the warrants, could pressure the stock price and dilute existing shareholders. Wrap’s stock trades on Nasdaq under the symbol WRAP, and the closing price on February 12, 2026 was $1.70 per share, below the common warrant exercise price.